GlassScriptPhysician profile
Stan J Whitney
NPI 1942306824
$16,330.95
in general payments reported to CMS, 2019-2025
62 companies · $2,490 in 2025
The $2,490 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,005 · 2020: $1,767 · 2021: $2,598 · 2022: $2,816 · 2023: $2,446 · 2024: $2,209 · 2025: $2,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,145.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,289.15 | 2019-2025 | Qulipta, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $1,142.79 | 2019-2025 | |
| Lilly USA, LLC | $1,122.61 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Ucb, INC. | $1,005.44 | 2019-2025 | Fintepla, Briviact, Zilbrysq |
| Eisai INC. | $875.06 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $774.17 | 2019-2025 | Ultomiris |
| Biogen, INC. | $710.63 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Pfizer INC. | $660.66 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $656.79 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Amgen INC. | $623.60 | 2019-2025 | Uplizna |
| Emd Serono, INC. | $567.68 | 2019-2025 | Mavenclad, Mavenclad |
| Genzyme Corporation | $524.81 | 2019-2023 | |
| Lundbeck LLC | $438.62 | 2020-2024 | Vyepti, Rexulti |
| Genentech USA, INC. | $368.30 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Greenwich Biosciences, INC. | $363.03 | 2019-2021 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stan Whitney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.